Related references
Note: Only part of the references are listed.Targeting Spare CC Chemokine Receptor 5 (CCR5) as a Principle to Inhibit HIV-1 Entry
Jun Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CCR5 Conformations Are Dynamic and Modulated by Localization, Trafficking and G Protein Association
Ayanna J. Flegler et al.
PLOS ONE (2014)
Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop
Phanourios Tamamis et al.
PLOS ONE (2014)
Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor
Ravinder Abrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
HIV-1 Dynamics and Coreceptor Usage in Maraviroc-Treated Patients with Ongoing Replication
P. Recordon-Pinson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Entry inhibitors and their use in the treatment of HIV-1 infection
Aiman A. Haqqani et al.
ANTIVIRAL RESEARCH (2013)
Ultrasensitive analysis of binding affinity of HIV receptor and neutralizing antibodies using solution-phase electrochemiluminescence assay
Xiao-Hong Nancy Xu et al.
JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2013)
HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120
Annette N. Ratcliff et al.
JOURNAL OF VIROLOGY (2013)
Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5
Zahra F. Parker et al.
JOURNAL OF VIROLOGY (2013)
Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants
Reem Berro et al.
JOURNAL OF VIROLOGY (2013)
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines
Philippe Colin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
Michael Roche et al.
RETROVIROLOGY (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Jean-Philippe Julien et al.
SCIENCE (2013)
Affinofile profiling: How efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV
Kelechi Chikere et al.
VIROLOGY (2013)
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets
Jacqueline K. Flynn et al.
VIROLOGY (2013)
A Synthetic Heparan Sulfate-Mimetic Peptide Conjugated to a Mini CD4 Displays Very High Anti-HIV-1 Activity Independently of Coreceptor Usage
Bridgette Janine Connell et al.
CHEMISTRY & BIOLOGY (2012)
HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug
Opass Putcharoen et al.
JOURNAL OF VIROLOGY (2012)
Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures
Athe M. N. Tsibris et al.
JOURNAL OF VIROLOGY (2012)
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc
Reem Berro et al.
VIROLOGY (2012)
New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection
Javier Garcia-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
Javier Garcia-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Molecular Epidemiologic Analysis of Methicillin-Resistant Staphylococcus aureus Isolates from Bacteremia and Nasal Colonization at 10 Intensive Care Units: Multicenter Prospective Study in Korea
Jae-Cheol Kwon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors
Reem Berro et al.
JOURNAL OF VIROLOGY (2011)
HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism
Michael Roche et al.
JOURNAL OF VIROLOGY (2011)
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
Michael Roche et al.
RETROVIROLOGY (2011)
CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity
Jasminka Sterjovski et al.
VIROLOGY (2011)
A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
John C. Tilton et al.
JOURNAL OF VIROLOGY (2010)
HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
Jennifer M. Pfaff et al.
JOURNAL OF VIROLOGY (2010)
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility
Marie Pancera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5
Robert A. Ogert et al.
VIROLOGY (2010)
Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step
Brooke Harmon et al.
PLOS PATHOGENS (2010)
Binding Thermodynamics of the N-Terminal Peptide of the CCR5 Coreceptor to HIV-1 Envelope Glycoprotein gp120
Evan T. Brower et al.
BIOCHEMISTRY (2009)
Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4
Caroline Agrawal-Gamse et al.
JOURNAL OF VIROLOGY (2009)
A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains
Samantha H. Johnston et al.
JOURNAL OF VIROLOGY (2009)
Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
Cleo G. Anastassopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities
Pavel Pugach et al.
VIROLOGY (2009)
A piece de resistance: how HIV-1 escapes small molecule CCR5 inhibitors
John P. Moore et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
Reem Berro et al.
PLOS PATHOGENS (2009)
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject
Athe M. N. Tsibris et al.
JOURNAL OF VIROLOGY (2008)
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1
Alonso Heredia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors
Katrina M. Nolan et al.
JOURNAL OF VIROLOGY (2008)
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
Chih-chin Huang et al.
SCIENCE (2007)
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists
George Lin et al.
JOURNAL OF VIROLOGY (2007)
The role of the N-terminal segment of CCR5 in HIV-I Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment
Gregory B. Melikyan et al.
RETROVIROLOGY (2007)
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies
Meg M. Laakso et al.
PLOS PATHOGENS (2007)
Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss
Cleo G. Anastassopoulou et al.
PLOS PATHOGENS (2007)
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach et al.
VIROLOGY (2007)
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
Mike Westby et al.
JOURNAL OF VIROLOGY (2007)
A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1
J. Garcia-Perez et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia
Rebecca L. Dunfee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structure of a V3-containing HIV-1 gp120 core
CC Huang et al.
SCIENCE (2005)
Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion
SR Mkrtchyan et al.
JOURNAL OF VIROLOGY (2005)
Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers
ID Alves et al.
BIOCHEMISTRY (2005)
Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry
AJ Marozsan et al.
JOURNAL OF VIROLOGY (2005)
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis
B Lagane et al.
MOLECULAR PHARMACOLOGY (2005)
Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus
EJ Platt et al.
JOURNAL OF VIROLOGY (2005)
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor
SE Kuhmann et al.
JOURNAL OF VIROLOGY (2004)
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations
Y Duan et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains
SH Xiang et al.
VIROLOGY (2003)
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics
JD Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
M Cavrois et al.
NATURE BIOTECHNOLOGY (2002)
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor
EG Cormier et al.
JOURNAL OF VIROLOGY (2002)
Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies
C Blanpain et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4
WT Zhang et al.
BIOCHEMISTRY (2001)
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120
EG Cormier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
